Quality of Life in Patients With Multiple Myeloma-validation Study

Zurich University of Applied Sciences

Status: Terminated

Conditions: Multiple Myeloma

Treatments: Diagnostic Test: Myeloma Patient Outcome Scale (MyPOS)

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT03537222

97107155001701

Details and patient eligibility

About

In this study, the Myeloma Patient Outcome Scale (MyPOS) will be translated from English to German. This translated version will be quantitatively and qualitatively validated with patients with multiple myeloma.

Full description

Patients with multiple myeloma (N=10) will be interviewed in the qualitative phase about their comprehension of the translated MyPOS. The questionnaire will be revised according to the results of the interviews. This culturally adapted Swiss-German MyPOS will be assessed in the quantitative phase for its' psychometric properties with 200 patients with multiple myeloma.

Enrollment: 58 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• informed consent as documented by signature
• confirmed histological diagnosis of multiple myeloma,
• age ≥ 18 years,
• mental capacity to give written informed consent

Exclusion criteria

• inability to communicate in German
• participation in another clinical study
• more than one cancer diagnosis
• mental illness (i.e. psychiatric diagnosis)

Trial design

58 participants in 1 patient group

MyPOS

Treatment:

Diagnostic Test: Myeloma Patient Outcome Scale (MyPOS)